Benchtop manufacturing gets smaller

MIT scientists continue to break new ground in benchtop manufacturing systems for biologics. Published in Nature Biotechnology last month, the latest advance from the institute centered on an automated, closed system capable of producing clinical-grade therapeutic proteins in three days.

Christopher Love, who led the project, says his Integrated Scalable Cyto-Technology (InSCyT) system brings the field closer to a vision of regionalized, small-footprint production. ...